IRIS
BERTONI, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.324
AS - Asia 6.603
EU - Europa 5.762
SA - Sud America 826
AF - Africa 386
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 6
Totale 23.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.067
SG - Singapore 2.342
CN - Cina 1.991
VN - Vietnam 1.041
FI - Finlandia 975
IT - Italia 963
IE - Irlanda 804
SE - Svezia 783
BR - Brasile 658
DE - Germania 596
UA - Ucraina 464
HK - Hong Kong 447
FR - Francia 244
ZA - Sudafrica 243
NL - Olanda 238
GB - Regno Unito 235
TR - Turchia 193
CA - Canada 161
IN - India 139
RU - Federazione Russa 113
BD - Bangladesh 80
BE - Belgio 73
AR - Argentina 65
CI - Costa d'Avorio 65
ES - Italia 56
AT - Austria 49
MX - Messico 49
JP - Giappone 43
CZ - Repubblica Ceca 42
TH - Thailandia 38
IQ - Iraq 35
PH - Filippine 35
KR - Corea 32
PK - Pakistan 32
PL - Polonia 31
ID - Indonesia 28
EC - Ecuador 24
CO - Colombia 21
RO - Romania 20
EU - Europa 17
MA - Marocco 17
VE - Venezuela 16
LT - Lituania 15
TW - Taiwan 15
EG - Egitto 14
MY - Malesia 13
PY - Paraguay 12
UZ - Uzbekistan 11
ET - Etiopia 10
JM - Giamaica 10
KE - Kenya 10
PA - Panama 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
CL - Cile 9
HU - Ungheria 9
IR - Iran 9
AZ - Azerbaigian 8
NP - Nepal 8
TN - Tunisia 8
JO - Giordania 7
CR - Costa Rica 6
UY - Uruguay 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HR - Croazia 5
KZ - Kazakistan 5
PE - Perù 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
DK - Danimarca 4
HN - Honduras 4
IL - Israele 4
LB - Libano 4
MD - Moldavia 4
OM - Oman 4
PT - Portogallo 4
QA - Qatar 4
SI - Slovenia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
EE - Estonia 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
BN - Brunei Darussalam 2
CM - Camerun 2
LY - Libia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AM - Armenia 1
BB - Barbados 1
Totale 23.906
Salva come PNG Salva come JPEG
Città #
Dallas 2.931
Singapore 1.272
Ashburn 933
Dublin 803
Chandler 790
San Jose 609
Santa Clara 503
Jacksonville 493
Beijing 466
Hong Kong 414
Ann Arbor 383
Dearborn 376
Ho Chi Minh City 321
Parma 305
Boardman 275
Johannesburg 231
Hanoi 211
New York 195
Nanjing 187
Munich 176
Shanghai 156
Izmir 154
Los Angeles 147
Princeton 138
Lauterbourg 137
Wilmington 107
Hefei 91
San Mateo 90
Helsinki 84
Toronto 82
São Paulo 68
Abidjan 65
Brussels 65
Hebei 64
Buffalo 63
Nanchang 62
Kunming 60
Bremen 55
Guangzhou 55
Jinan 54
Moscow 54
Shenyang 50
Frankfurt am Main 49
Haiphong 48
Chicago 47
Woodbridge 44
Changsha 43
Bologna 40
London 40
Seattle 40
Da Nang 39
Vienna 38
Des Moines 37
Montreal 34
Tokyo 34
Groningen 33
Tianjin 33
Milan 32
Council Bluffs 30
Turku 30
Columbus 29
Bangalore 27
Brooklyn 27
Grafing 27
Marseille 27
Amsterdam 25
Auburn Hills 24
Fremont 24
Norwalk 24
Brno 23
Rio de Janeiro 23
Warsaw 23
Houston 22
Reggio Emilia 22
Hangzhou 21
Jiaxing 21
Orem 21
Zhengzhou 20
Atlanta 19
Hải Dương 17
Manchester 17
Nuremberg 17
Stockholm 17
Bangkok 16
Chennai 16
Curitiba 16
Belo Horizonte 15
Brescia 15
Denver 15
Jakarta 15
Madrid 15
Mexico City 15
Pune 15
Rome 15
Boston 14
Dhaka 14
Modena 14
Ottawa 14
Redondo Beach 14
The Dalles 14
Totale 15.235
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.683
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.628
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 250
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 240
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 239
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 219
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 210
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 207
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 204
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 202
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 196
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 196
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 192
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 191
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 190
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 190
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 189
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 187
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach 184
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 182
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 179
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 176
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 176
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 175
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 174
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 174
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 174
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 169
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 167
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 166
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 166
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 165
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 164
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 163
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 163
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 162
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 161
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 161
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 160
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 160
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 160
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 159
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 159
Analgesic activity of new hybrid muscarinic agonists in mice 159
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 157
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 156
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 156
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 156
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 155
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 152
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 152
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 151
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 149
Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats 149
Influence of Nitric Oxide system in mesenteric ischemia-reperfusion induced injury in mice 148
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 148
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 147
Motor responses of rat hypertrophic intestine following chronic obstruction 147
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 146
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 146
PHARMACOLOGICAL CHARACTERIZATION OF NEW COMPOUNDS AIMED AT INHIBITING EPH-EPHRIN INTERACTION IN GLIOBLASTOMA 145
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 144
CNS access of selected H3-antagonists: ex vivo binding study in rats 143
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 143
Influence of gender in the mesenteric ischemia/reperfusion model in mice 141
Benzofuran-2-Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20-Induced Chemotaxis and Colon Cancer Growth 140
The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice 140
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 140
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 138
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 138
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 138
Up-regulation of inhibitory transmitters in myenteric neurons of the rat ileum in an acute model of ischemia/reperfusion 138
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 138
Heterogeneous response of colonoid-derived monolayers to TNFa and IFNg exposure: functional and morphological characterization 136
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 136
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 136
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 135
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 135
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 133
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 132
RESPONSIVENESS OF LONGITUDINAL AND CIRCULAR MUSCLE TO RELAXING MEDIATORS IS DIFFERENTIALLY AFFECTED IN RAT HYPERTROPHIED ILEUM 132
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 132
Role of Glutamate- N-methyl-D-Aspartate (NMDA) Receptors in Neuronal Plasticity and Gastrointestinal Transit Delay Induced by Ischemia/Reperfusion in Rats 132
Evidence for the involvement of 5-HT(2A) receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice 130
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 129
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 128
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 127
Protection by the EPH-EPHRIN System Against Mesenteric Ischemia-Reperfusion Injury 127
Involvement of 5-HT2A receptors in motor and inflammatory disorders induced by mesenteric ischemia reperfusion in mice 123
Allosteric Modulation of Muscarinic Acetylcholine-Receptors: Oxotremorine-Phthalimidoalkyl-Hybrids of the Hexamethonio-type 122
PHENYLPROPANOID RICH ESSENTIAL OILS AS POTENTIAL ANTITHROMBOTICS ENDOWED WITH GASTROPROTECTIVE EFFECTS 122
Synthesis and functional characterization of novel heterocyclic derivatives related to oxotremorine and oxotremorine-M 121
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 121
New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes 120
Interactions of new and conventional H3-blockers with non-histaminergic receptors involved in neurogenic and myogenic contractile responses of guinea-pig ileum 120
Glutamate receptor activation mediates the effects of ischemia/reperfusion on gastrointestinal transit and neuronal phenotypes in the rat myenteric plexus 119
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 119
In vitro characterization of potency, affinity and selectivity of H3-antagonists: from thioperamide to thioperamide unrelated derivatives 119
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 118
Totale 18.678
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 43 140 24
2021/2022836 32 23 32 91 51 56 94 104 33 58 58 204
2022/20233.138 347 320 181 234 320 344 67 174 932 45 121 53
2023/20241.227 69 80 46 47 88 313 126 84 38 66 97 173
2024/20253.732 137 193 260 237 383 430 157 168 398 367 271 731
2025/202610.140 842 1.238 2.826 796 1.127 476 871 282 1.144 538 0 0
Totale 24.093